guest ::
| Home > Publications Database > Distribution patterns of tau pathology in progressive supranuclear palsy > print |
| Home > Publications Database > Distribution patterns of tau pathology in progressive supranuclear palsy > print |
| 001 | 151075 | ||
| 005 | 20240323120022.0 | ||
| 024 | 7 | _ | |a pmc:PMC7360645 |2 pmc |
| 024 | 7 | _ | |a 10.1007/s00401-020-02158-2 |2 doi |
| 024 | 7 | _ | |a 0001-6322 |2 ISSN |
| 024 | 7 | _ | |a 1432-0533 |2 ISSN |
| 024 | 7 | _ | |a altmetric:81560340 |2 altmetric |
| 024 | 7 | _ | |a pmid:32383020 |2 pmid |
| 037 | _ | _ | |a DZNE-2020-01060 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Kovacs, Gabor G. |0 0000-0003-3841-5511 |b 0 |
| 245 | _ | _ | |a Distribution patterns of tau pathology in progressive supranuclear palsy |
| 260 | _ | _ | |a Heidelberg |c 2020 |b Springer |
| 264 | _ | 1 | |3 online |2 Crossref |b Springer Science and Business Media LLC |c 2020-05-07 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2020-08-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1711118609_19996 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Progressive supranuclear palsy (PSP) is a 4R-tauopathy predominated by subcortical pathology in neurons, astrocytes, and oligodendroglia associated with various clinical phenotypes. In the present international study, we addressed the question of whether or not sequential distribution patterns can be recognized for PSP pathology. We evaluated heat maps and distribution patterns of neuronal, astroglial, and oligodendroglial tau pathologies and their combinations in different clinical subtypes of PSP in postmortem brains. We used conditional probability and logistic regression to model the sequential distribution of tau pathologies across different brain regions. Tau pathology uniformly predominates in the neurons of the pallido-nigro-luysian axis in different clinical subtypes. However, clinical subtypes are distinguished not only by total tau load but rather cell-type (neuronal versus glial) specific vulnerability patterns of brain regions suggesting distinct dynamics or circuit-specific segregation of propagation of tau pathologies. For Richardson syndrome (n = 81) we recognize six sequential steps of involvement of brain regions by the combination of cellular tau pathologies. This is translated to six stages for the practical neuropathological diagnosis by the evaluation of the subthalamic nucleus, globus pallidus, striatum, cerebellum with dentate nucleus, and frontal and occipital cortices. This system can be applied to further clinical subtypes by emphasizing whether they show caudal (cerebellum/dentate nucleus) or rostral (cortical) predominant, or both types of pattern. Defining cell-specific stages of tau pathology helps to identify preclinical or early-stage cases for the better understanding of early pathogenic events, has implications for understanding the clinical subtype-specific dynamics of disease-propagation, and informs tau-neuroimaging on distribution patterns. |
| 536 | _ | _ | |a 344 - Clinical and Health Care Research (POF3-344) |0 G:(DE-HGF)POF3-344 |c POF3-344 |f POF III |x 0 |
| 542 | _ | _ | |i 2020-05-07 |2 Crossref |u https://creativecommons.org/licenses/by/4.0 |
| 588 | _ | _ | |a Dataset connected to CrossRef |
| 650 | _ | 2 | |a Aged |2 MeSH |
| 650 | _ | 2 | |a Brain: pathology |2 MeSH |
| 650 | _ | 2 | |a Cohort Studies |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Middle Aged |2 MeSH |
| 650 | _ | 2 | |a Supranuclear Palsy, Progressive: pathology |2 MeSH |
| 650 | _ | 2 | |a tau Proteins: analysis |2 MeSH |
| 700 | 1 | _ | |a Irwin, David J. |b 1 |
| 700 | 1 | _ | |a Jecmenica Lukic, Milica |0 P:(DE-2719)2812616 |b 2 |u dzne |
| 700 | 1 | _ | |a Arzberger, Thomas |0 P:(DE-2719)2811333 |b 3 |
| 700 | 1 | _ | |a Respondek, Gesine |0 P:(DE-2719)2811600 |b 4 |
| 700 | 1 | _ | |a Lee, Edward B. |b 5 |
| 700 | 1 | _ | |a Coughlin, David |0 0000-0003-4111-0102 |b 6 |
| 700 | 1 | _ | |a Giese, Armin |0 P:(DE-HGF)0 |b 7 |
| 700 | 1 | _ | |a Grossman, Murray |b 8 |
| 700 | 1 | _ | |a Kurz, Carolin |0 P:(DE-2719)9000176 |b 9 |
| 700 | 1 | _ | |a McMillan, Corey T. |b 10 |
| 700 | 1 | _ | |a Gelpi, Ellen |b 11 |
| 700 | 1 | _ | |a Compta, Yaroslau |b 12 |
| 700 | 1 | _ | |a van Swieten, John C. |b 13 |
| 700 | 1 | _ | |a Laat, Laura Donker |b 14 |
| 700 | 1 | _ | |a Troakes, Claire |b 15 |
| 700 | 1 | _ | |a Al-Sarraj, Safa |b 16 |
| 700 | 1 | _ | |a Robinson, John L. |b 17 |
| 700 | 1 | _ | |a Roeber, Sigrun |b 18 |
| 700 | 1 | _ | |a Xie, Sharon X. |b 19 |
| 700 | 1 | _ | |a Lee, Virginia M.- Y. |b 20 |
| 700 | 1 | _ | |a Trojanowski, John Q. |0 P:(DE-HGF)0 |b 21 |
| 700 | 1 | _ | |a Höglinger, Günter U. |0 P:(DE-2719)2811373 |b 22 |e Last author |
| 773 | 1 | 8 | |a 10.1007/s00401-020-02158-2 |b : Springer Science and Business Media LLC, 2020-05-07 |n 2 |p 99-119 |3 journal-article |2 Crossref |t Acta Neuropathologica |v 140 |y 2020 |x 0001-6322 |
| 773 | _ | _ | |a 10.1007/s00401-020-02158-2 |g Vol. 140, no. 2, p. 99 - 119 |0 PERI:(DE-600)1458410-4 |n 2 |p 99-119 |t Acta neuropathologica |v 140 |y 2020 |x 0001-6322 |
| 856 | 4 | _ | |u https://link.springer.com/article/10.1007%2Fs00401-020-02158-2 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/151075/files/DZNE-2020-01060.pdf |y OpenAccess |
| 856 | 4 | _ | |u https://pub.dzne.de/record/151075/files/DZNE-2020-01060.pdf?subformat=pdfa |x pdfa |y OpenAccess |
| 909 | C | O | |o oai:pub.dzne.de:151075 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2812616 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2811333 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)2811600 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)9000176 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 22 |6 P:(DE-2719)2811373 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-344 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 914 | 1 | _ | |y 2020 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2019-12-20 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2019-12-20 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-29 |
| 915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b ACTA NEUROPATHOL : 2021 |d 2022-11-29 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ACTA NEUROPATHOL : 2021 |d 2022-11-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-29 |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2019-12-20 |w ger |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-29 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-29 |
| 920 | 1 | _ | |0 I:(DE-2719)6000016 |k München common |l München common |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1110002 |k AG Höglinger 1 |l Translational Neurodegeneration |x 1 |
| 920 | 1 | _ | |0 I:(DE-2719)1111016 |k AG Levin |l Clinical Neurodegeneration |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)6000016 |
| 980 | _ | _ | |a I:(DE-2719)1110002 |
| 980 | _ | _ | |a I:(DE-2719)1111016 |
| 980 | 1 | _ | |a FullTexts |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/awm301 |2 Crossref |o 10.1093/brain/awm301 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00401-018-1900-5 |2 Crossref |o 10.1007/s00401-018-1900-5 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/BF00308809 |2 Crossref |o 10.1007/BF00308809 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/S0197-4580(02)00065-9 |2 Crossref |o 10.1016/S0197-4580(02)00065-9 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/bf03161076 |2 Crossref |o 10.1007/bf03161076 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1097/WCO.0b013e32833be924 |2 Crossref |o 10.1097/WCO.0b013e32833be924 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1097/NEN.0000000000000046 |2 Crossref |o 10.1097/NEN.0000000000000046 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.parkreldis.2011.02.017 |2 Crossref |o 10.1016/j.parkreldis.2011.02.017 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00401-019-02035-7 |2 Crossref |o 10.1007/s00401-019-02035-7 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/ana.23844 |2 Crossref |o 10.1002/ana.23844 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1001/jamaneurol.2018.2505 |2 Crossref |o 10.1001/jamaneurol.2018.2505 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/awh596 |2 Crossref |o 10.1093/brain/awh596 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1212/wnl.44.11.2015 |2 Crossref |o 10.1212/wnl.44.11.2015 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/mds.26987 |2 Crossref |o 10.1002/mds.26987 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/ana.24559 |2 Crossref |o 10.1002/ana.24559 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1186/s40478-019-0664-z |2 Crossref |o 10.1186/s40478-019-0664-z |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/mds.27198 |2 Crossref |o 10.1002/mds.27198 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1111/nan.12208 |2 Crossref |o 10.1111/nan.12208 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/jclinpath-2019-205952 |2 Crossref |o 10.1136/jclinpath-2019-205952 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1111/bpa.12536 |2 Crossref |o 10.1111/bpa.12536 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00401-013-1157-y |2 Crossref |o 10.1007/s00401-013-1157-y |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/jnen/nlx007 |2 Crossref |o 10.1093/jnen/nlx007 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/jnen/nlx041 |2 Crossref |o 10.1093/jnen/nlx041 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1186/s40478-018-0552-y |2 Crossref |o 10.1186/s40478-018-0552-y |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.2307/2529310 |2 Crossref |o 10.2307/2529310 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/978-3-7091-6641-3_11 |2 Crossref |o 10.1007/978-3-7091-6641-3_11 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1111/nan.12037 |2 Crossref |o 10.1111/nan.12037 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/aww256 |2 Crossref |o 10.1093/brain/aww256 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1159/000365548 |2 Crossref |o 10.1159/000365548 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1272/jnms.82.266 |2 Crossref |o 10.1272/jnms.82.266 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/mds.27872 |2 Crossref |o 10.1002/mds.27872 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/mds.26054 |2 Crossref |o 10.1002/mds.26054 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/awy146 |2 Crossref |o 10.1093/brain/awy146 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.pneurobio.2019.101644 |2 Crossref |o 10.1016/j.pneurobio.2019.101644 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/jnen/63.9.911 |2 Crossref |o 10.1093/jnen/63.9.911 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/mds.27816 |2 Crossref |o 10.1002/mds.27816 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1111/j.1440-1789.2010.01134.x |2 Crossref |o 10.1111/j.1440-1789.2010.01134.x |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00415-011-6205-8 |2 Crossref |o 10.1007/s00415-011-6205-8 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/ana.25060 |2 Crossref |o 10.1002/ana.25060 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.parkreldis.2019.07.010 |2 Crossref |o 10.1016/j.parkreldis.2019.07.010 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00401-016-1650-1 |2 Crossref |o 10.1007/s00401-016-1650-1 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1055/s-0034-1381740 |2 Crossref |o 10.1055/s-0034-1381740 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.jalz.2013.06.003 |2 Crossref |o 10.1016/j.jalz.2013.06.003 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/mds.20478 |2 Crossref |o 10.1002/mds.20478 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00259-018-4031-2 |2 Crossref |o 10.1007/s00259-018-4031-2 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/awh488 |2 Crossref |o 10.1093/brain/awh488 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/awm104 |2 Crossref |o 10.1093/brain/awm104 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1111/bpa.12265 |2 Crossref |o 10.1111/bpa.12265 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00401-016-1665-7 |2 Crossref |o 10.1007/s00401-016-1665-7 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|